I have 32 years of experience, and specialize in the field of antiviral chemotherapy with specific knowledge in the areas of pre-clinical drug development in cell culture and animal models, working with pharmaceutical companies and evaluating scientific data pertaining to this field. I have published on such topics as anti-herpes compounds related to acyclovir and ganciclovir, the anti-influenza compounds related to oseltamivir and zanamivair and antiviral compounds related to ribavirin. I have testified on anti-herpes approved Federal Drug Administration drug. I have professional experience in industry, academia, and working for the government. My field of expertise is applied, i.e., to assist in antiviral drug development.